Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides

Annals of the New York Academy of Sciences

Volumn 1150, Issue , 2008, Pages 171-176

  Reddy, Shiva ^a   Cheung, Carlos Chun Ho ^a   Chai, Ryan Chau Chia ^a   Rodrigues, Jessica Astrid ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Autoimmunity; Beta cells; Peptide therapy; Reversal of type 1 diabetes

Indexed keywords

EPIDERMAL GROWTH FACTOR; GASTRIN; GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; CELL ACTIVITY; CELL FATE; CELL INFILTRATION; CELL REGENERATION; CONFERENCE PAPER; DISEASE DURATION; EXPERIMENTAL DESIGN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INSULITIS; LONG TERM CARE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; REMISSION; RESIDUAL BETA CELL; TREATMENT OUTCOME;

MUS;

EID: 57749182172     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1447.010     Document Type: Conference Paper

References (18)

1. Ablamunits, V., N.A. Sherry, J.A. Kushner & K.C. Herold. 2007. Autoimmunity and β cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann. N.Y. Acad. Sci. 1103 : 19 32.
2. Foulis, A.K. & J.A. Stewart. 1984. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26 : 456 461.
3. Foulis, A.K., C.N. Liddle, M.A. Farquharson, et al. 1986. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29 : 267 274.
4. Dotta, F., S. Censini, A.G. Van Halteren, et al. 2007. Coxackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 104 : 5115 5120.
5. Palmer, J.P., G.A. Fleming, C.J. Greenbaum, et al. 2004. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: report of an ADA Workshop, 21-22 October 2001. Diabetes 53 : 250 264.
6. Sherry, N.A., W. Chen, J.A. Kushner, et al. 2007. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of β-cells. Endocrinology 148 : 5136 5144.
7. Reddy, S., R.C.C. Chai, J.A. Rodrigues, et al. 2008. Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during long-standing diabetes: a combined histochemical and immunohistochemical study. J. Mol. Hist. 39 : 25 36.
8. Ogawa, N., J.F. List, J.F. Habener & T. Maki. 2004. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53 : 1700 1705.
9. Yang, Z., M. Chen, J.D. Carter, et al. 2006. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. Biochem. Biophys. Res. Commun. 344 : 1017 1022.
10. Rooman, I. & L. Bouwens. 2004. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 47 : 259 265.
11. Suarez-Pinzon, W.L., Y. Yan, R. Power, et al. 2005. Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycaemia in diabetic NOD mice. Diabetes 54 : 2596 2601.
12. Muhammad, B.J., P.G. Swift, N.T. Raymond & J.L. Botha. 1999. Partial remission phase of diabetes in children younger than age 10 years. Arch. Dis. Child. 80 : 367 369.
13. Bober, E., B. Dundar & A. Buyukgebiz. 2001. Partial remission phase and metabolic control, in type 1 diabetes mellitus in children and adolescents. J. Paediatr. Endocrinol. Metab. 14 : 435 441.
14. Butler, P.C., J.J. Meier, A.E. Butler & A. Bhushan. 2007. The replication of β cells in normal physiology, in disease and for therapy. Nat. Clin. Prac. Endocrinol. Metab. 3 : 758 768.
15. Green, I.C. & K.W. Taylor. 1972. Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J. Endocrinology 54 : 317 325.
16. Butler, A.E., J. Janson, S. Bonner-Weir, et al. 2003. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 : 102 110.
17. Thorens, B., Y-J. Wu, J.L. Leahey & G.C. Weir. 1992. The loss of GLUT2 expression by glucose-unresponsive β cells of db/db mice is reversible and is induced by the diabetic environment. J. Clin. Invest. 90 : 77 85.
18. Reddy, S., M. Young, C.A. Poole & J.M. Ross. 1998. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy. Gen. Comp. Endocrinol. 111 : 9 19.